InvestorsHub Logo
Followers 2
Posts 1360
Boards Moderated 0
Alias Born 01/05/2018

Re: urge2surge post# 17661

Monday, 07/26/2021 2:14:15 PM

Monday, July 26, 2021 2:14:15 PM

Post# of 21540
They did miss all their primary endpoints. All this talk about positive results is based on a post-hoc analysis.

First trial failure is blamed on Namenda and second one on baseline imbalance. That's why they're currently running a third one that excludes those factors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News